JP2009082138A5 - - Google Patents

Download PDF

Info

Publication number
JP2009082138A5
JP2009082138A5 JP2008301520A JP2008301520A JP2009082138A5 JP 2009082138 A5 JP2009082138 A5 JP 2009082138A5 JP 2008301520 A JP2008301520 A JP 2008301520A JP 2008301520 A JP2008301520 A JP 2008301520A JP 2009082138 A5 JP2009082138 A5 JP 2009082138A5
Authority
JP
Japan
Prior art keywords
temperature
medium
hmba
cell line
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008301520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009082138A (ja
JP4414472B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2009082138A publication Critical patent/JP2009082138A/ja
Publication of JP2009082138A5 publication Critical patent/JP2009082138A5/ja
Application granted granted Critical
Publication of JP4414472B2 publication Critical patent/JP4414472B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2008301520A 2002-03-27 2008-11-26 ポリペプチド産生を増加させる方法 Expired - Lifetime JP4414472B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36824802P 2002-03-27 2002-03-27
US36824602P 2002-03-27 2002-03-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003580502A Division JP2005521401A (ja) 2002-03-27 2003-03-27 ポリペプチド産生を増加させる方法

Publications (3)

Publication Number Publication Date
JP2009082138A JP2009082138A (ja) 2009-04-23
JP2009082138A5 true JP2009082138A5 (https=) 2009-06-04
JP4414472B2 JP4414472B2 (ja) 2010-02-10

Family

ID=28678222

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003580502A Pending JP2005521401A (ja) 2002-03-27 2003-03-27 ポリペプチド産生を増加させる方法
JP2008024395A Expired - Lifetime JP4414466B2 (ja) 2002-03-27 2008-02-04 ポリペプチド産生を増加させる方法
JP2008301520A Expired - Lifetime JP4414472B2 (ja) 2002-03-27 2008-11-26 ポリペプチド産生を増加させる方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2003580502A Pending JP2005521401A (ja) 2002-03-27 2003-03-27 ポリペプチド産生を増加させる方法
JP2008024395A Expired - Lifetime JP4414466B2 (ja) 2002-03-27 2008-02-04 ポリペプチド産生を増加させる方法

Country Status (9)

Country Link
US (2) US6872549B2 (https=)
EP (1) EP1497444B1 (https=)
JP (3) JP2005521401A (https=)
AU (1) AU2003220529B2 (https=)
CA (1) CA2480121C (https=)
ES (1) ES2557741T3 (https=)
MX (1) MXPA04009381A (https=)
PL (1) PL376821A1 (https=)
WO (1) WO2003083066A2 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050005310A1 (en) * 1999-07-12 2005-01-06 Genentech, Inc. Expression vectors and methods
US6872549B2 (en) * 2002-03-27 2005-03-29 Immunex Corporation Methods for increasing polypeptide production
US20050019925A1 (en) * 2002-11-14 2005-01-27 Genentech, Inc. Intron fusion construct and method of using for selecting high-expressing production cell lines
US20040265964A1 (en) * 2003-04-25 2004-12-30 Martin Allen Inducers of recombinant protein expression
AU2004266043B2 (en) * 2003-08-21 2007-09-20 Duchesnay Inc. Micronutrient supplement
AU2004266741B2 (en) * 2003-08-21 2008-01-03 Duchesnay Inc. Childproof micronutrient supplement
EP1697414A2 (en) * 2003-12-23 2006-09-06 Applied Research Systems ARS Holding N.V. Process for the production of tumor necrosis factor-binding proteins
MX2007015476A (es) 2005-06-14 2008-02-25 Amgen Inc Formulaciones de proteina autoamortiguadoras.
WO2007049567A1 (ja) * 2005-10-24 2007-05-03 Kyowa Hakko Kogyo Co., Ltd. 物質の製造方法
EP2253644B1 (en) 2005-12-20 2013-10-16 Bristol-Myers Squibb Company Compositions and methods for producing a composition
AR058568A1 (es) 2005-12-20 2008-02-13 Bristol Myers Squibb Co Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
EP2623986B1 (en) 2006-02-10 2017-06-14 Life Technologies Corporation Labeling and detection of post translationally modified proteins
US8247187B2 (en) * 2006-08-14 2012-08-21 Biocontrol Systems, Inc. Method for detecting pathogens
TWI456062B (zh) 2006-09-13 2014-10-11 Abbvie Inc 細胞培養改良
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
WO2008121711A1 (en) * 2007-03-28 2008-10-09 Medarex, Inc. Methods of gene amplification and expression
TW200902708A (en) * 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
US20090023186A1 (en) * 2007-07-22 2009-01-22 Excellgene Sa Use of valproic acid for enhancing production of recombinant proteins in mammalian cells
EP2257634A1 (en) * 2008-03-12 2010-12-08 Wyeth LLC Method for identifying cells suitable for large-scale production of recombinant proteins
JP2013512674A (ja) * 2009-12-02 2013-04-18 アクセルロン ファーマ， インコーポレイテッド Ｆｃ融合タンパク質の血清半減期を増加させるための組成物および方法
WO2012043754A1 (ja) 2010-09-30 2012-04-05 ダイキン工業株式会社 ドリップ防止剤、並びに、樹脂組成物
JP6001456B2 (ja) * 2010-12-28 2016-10-05 中外製薬株式会社 動物細胞の培養方法
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
EP2718328A4 (en) 2011-06-08 2014-12-24 Acceleron Pharma Inc COMPOSITIONS AND METHODS FOR INCREASING THE HALF TIME OF SERUM
DK2726600T3 (en) 2011-07-01 2017-05-15 Amgen Inc Mammalian Cell Culture
EP2653548A1 (de) 2012-04-17 2013-10-23 Greenovation Biotech GmbH Verfahren zur Erhöhung der Sekretion rekombinanter Proteine
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
BR112015022471A2 (pt) * 2013-03-15 2017-08-22 Theocorp Holding Co Llc Composições de teobromina úteis para aumentar o ganho de peso do feto e acentuar as propriedades ósseas
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
AU2017345490B2 (en) 2016-10-21 2022-07-07 Amgen Inc. Pharmaceutical formulations and methods of making the same
KR102190790B1 (ko) * 2018-10-19 2020-12-15 주식회사 프로젠 변형된 egf 단백질의 생산 방법
JP6963336B2 (ja) * 2017-10-23 2021-11-05 プロゲン・シーオー., エルティーディー.Progen Co., Ltd. 改変ｅｇｆタンパク質、その製造方法及びその使用
WO2022140389A1 (en) 2020-12-22 2022-06-30 Amgen Inc. Cell culture method
WO2026009803A1 (ja) * 2024-07-05 2026-01-08 国立大学法人九州大学 ヘパリン様物質を製造する方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3824286A (en) 1970-07-07 1974-07-16 Lever Brothers Ltd Preparation of polyacetylalkylene diamines
DE2961658D1 (en) 1978-05-17 1982-02-18 Thomae Gmbh Dr K Process for preparing human interferon
US4301249A (en) * 1980-07-23 1981-11-17 Merck & Co., Inc. High titer production of hepatitis A virus
US4357422A (en) 1980-08-14 1982-11-02 Massachusetts Institute Of Technology Method of enhancing interferon production
US4416986A (en) 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg
US4473647A (en) 1981-02-27 1984-09-25 Amf Inc. Tissue culture medium
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4992472A (en) 1987-06-16 1991-02-12 The United States Of America As Represented By The Department Of Health And Human Services Chemical differentiating agents
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US5055608A (en) 1988-11-14 1991-10-08 Sloan-Kettering Institute For Cancer Research Novel potent inducers of thermal differentiation and method of use thereof
US5330744A (en) 1988-11-14 1994-07-19 Sloan-Kettering Institute For Cancer Research Method for increasing sensitivity to chemically induced terminal differentiation
ZA899421B (en) 1988-12-14 1990-09-26 Merrell Dow Pharma Method of potentiating natural killer cell activity
CA2018228C (en) 1989-06-05 1996-02-27 Nancy L. Parenteau Cell culture systems and media
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
ATE194384T1 (de) 1989-09-12 2000-07-15 Hoffmann La Roche Tnf-bindende proteine
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272071A (en) 1989-12-22 1993-12-21 Applied Research Systems Ars Holding N.V. Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5369108A (en) 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
ATE240394T1 (de) 1992-10-23 2003-05-15 Immunex Corp Methoden zur herstellung löslicher, oligomerer proteine
US5420019A (en) 1993-02-02 1995-05-30 Xoma Corporation Stable bactericidal/permeability-increasing protein muteins
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US20010010922A1 (en) 1994-06-09 2001-08-02 Riccardo Dalla-Favera Cloning and uses of the genetic locus bcl-6
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
US5705364A (en) 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
AU708239B2 (en) 1995-06-29 1999-07-29 Immunex Corporation Cytokine that induces apoptosis
JP4306813B2 (ja) 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
USRE37234E1 (en) 1996-11-01 2001-06-19 Nitromed, Inc. Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
WO1998028010A2 (en) 1996-12-24 1998-07-02 Hyal Pharmaceutical Corporation Use of moieties for binding to hyaluronan and icam-1
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
AU1663599A (en) 1997-12-19 1999-07-12 Novo Nordisk A/S Method for producing heterologous proteins in eukaryotic cells on an industrial scale using nucleotide-manipulating agents
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
AU768269B2 (en) 1998-10-02 2003-12-04 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Apoptosis inducing agents and methods
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
IL145893A0 (en) 1999-04-26 2002-07-25 Genentech Inc Cell culture process for glycoproteins
CA2386180C (en) 1999-10-13 2010-03-09 Immunex Corporation Vectors and methods for recombinant protein expression
AU1920301A (en) 1999-11-17 2001-05-30 Immunex Corporation Receptor activator of nf-kappa b
AU5943201A (en) 2000-05-03 2001-11-12 Amgen Inc Modified peptides as therapeutic agents
US6872549B2 (en) * 2002-03-27 2005-03-29 Immunex Corporation Methods for increasing polypeptide production

Similar Documents

Publication Publication Date Title
JP2009082138A5 (https=)
CA2480121A1 (en) Methods for increasing polypeptide production
JP2013511280A5 (https=)
BR112012027282A2 (pt) meio de cultura de células aperfeiçoado
RU2009132986A (ru) Применение меди и глутамата в культуре клеток для производства полипептидов
JP2011512870A5 (https=)
CN104651287A (zh) 一种用于合成甘油葡糖苷的工程菌和应用
CN119101638A (zh) 一种共表达d-甘露醇脱氢酶和d-葡萄糖脱氢酶的工程菌及应用
AU2019400151A1 (en) Recombinant Escherichia coli system, construction method thereof, and usage in synthesis of α-1,2-fucosylated oligosaccharide
CN120192906B (zh) 一种生产胞磷胆碱的大肠杆菌重组工程菌及其构建方法与应用
KR102157781B1 (ko) 디카르복시산 생산을 위한 미생물 및 이를 이용한 디카르복시산 생산방법
Pembroke et al. Metabolic engineering of the model photoautotrophic cyanobacterium synechocystis for ethanol production: Optimization strategies and challenges
JP2009100702A5 (https=)
CN108473993A (zh) 中链氨基羧酸的生产方法
CN116334025A (zh) 一种RNA聚合酶β亚单位突变体及应用
CN103966249A (zh) 一种用于构建无筛选标签蓝细菌的载体及其应用
JP2025017371A5 (https=)
CN115895993B (zh) 一种促进胞嘧啶核苷三磷酸合成的方法
CN119242547A (zh) 一种提高l-组氨酸产量的大肠杆菌基因工程菌株的构建方法
CN118325930A (zh) 一种高产烟酰胺单核苷酸大肠杆菌工程菌及其构建方法和应用
WO2020134427A1 (zh) sll0528基因在提高集胞藻PCC6803乙醇耐受性中的应用
CN114075517B (zh) 马克斯克鲁维酵母工程菌株及其制备方法和生产乙醇的方法
CN116287066A (zh) 一种重组菌株生产脱氧胸苷三磷酸的方法
CN115851467B (zh) 一株过表达Cna1基因的重组酿酒酵母及其构建方法与应用
Kim et al. A novel bioreactor to study the dynamics of co-culture systems